References
- Pipkin F B. The renin-angiotensin system in normal and hypertensive pregnancies. “Hypertension in Pregnancy”, P C Rubin. Elsevier Science Publishers, Amsterdam 1988; 118–151
- Sibai B M, Schneider J M, Morrison J C, Lipschitz J, Anderson G D, Shier R W, Dilts P V. The late postpartum eclampsia controversy. Obstet Gynecol 1980; 55: 74–78
- Finnerty F A, Buchholz J, Guillaudeu R L. A pressor phenomenon associated with the postpartum period. JAMA 1957; 165: 778–780
- Davison J M, Lindheimer M D. Hypertension and pregnancy. “Diseases of the Kidney”, R W Schrier, C W Gottschalk. Little, Brown and Company, Boston 1988; 1653–1686
- Weir R J, Doig A, Fraser R, Morton J J, Parboosingh J, Roberton J I, Wilson A. Studies of the renin-angiotensin-aldosterone system, cortisol, DOC and ADH in normal and hypertensive pregnancy. “Hypertension in Pregnancy”, M D Lindheimer, A Katz, F Zuspan. John Wiley, New York 1979; 251–258
- Gant N F, Daley G L, Chand S, Whalley P J, MacDonald P C. A study of angiotensin II pressor responses throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682–2689
- Edwards B S, Zimmermman R S, Schwaf T R, Heublein D M, Burnett J C. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191–195
- Merkouris R W, Miller F C, Catanzarite V, Rigg L A, Quirk J G, Vesely D L. Increase in the plasma levels of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during normal pregnancy. Am J Obstet Gynecol 1990; 162: 859–864
- Steegers E AP, Hein P R, Tan A CITL, Groeneveld E AM, Jongsma H W, Benraad T J. Plasma atrial natriuretic peptide (ANP) in late pregnancy and puerperium. Eur J Obstet Gynecol Reprod Biol 1987; 26: 213–217
- Hirai N, Yanaihara T, Nakayama T, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide during normal pregnancy and in pregnancy complicated by hypertension. Am J Obstet Gynecol 1988; 159: 27–31
- Harber E, Koerner T, Page L B, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969; 29: 1349–1355
- Morimoto T, Aoyama M, Gotoh E, Shionoiri H. A method of radioimmunoassay of plasma angiotensin II using Florisil. Folia Endocrinol Jpn 1983; 59: 215–229
- Ogihara T, Iinuma K, Nishii K, Karakawa Y, Takagi A. A nonchromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab 1977; 45: 726–731
- Miyata A, Kangawa K, Toshimori T, Hatoh T, Matsuo H. Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasma. Biochem Biophys Res Commun 1985; 129: 248–255
- Steegers E AP, Hen P R, Groeneveld E AM, Jongsma H W, Tan A CITL, Benraad T J. Atrial natriuretic peptide concentrations during pregnancy. Lancet 1987; 1: 1267
- Gregoire I, Esper N, Gongry J, Boitte F, Fievet P, Makdassi R, Westeel P H, Lalau J D, Favrett Bold A, Fourmier A. Plasma atrial natriuretic factor and urinary excretion of a ouabain displacing factor and dopamine in normotensive pregnant women before and after delivery. Am J Obstet Gynecol 1990; 162: 71–76
- Lindheimer M D, Kats A I. Renal physiology pregnancy. “The Kidney, Physiology and Pathophysiology”, D W Seldin, D Giebish. Raven Press, New York 1985; 2017–2041
- Darison J M, Dunlop W. Changes in renal hemodynamics and tubular function induced by human normal pregnancy. Semin Nephrol 1984; 4: 198–207
- Atlas S A, Maack T. Effect of atrial natriuretic factor on the kidney and the renin-angiotensin-aldosterone system. Endocrinol Metab Clin North Am 1987; 16: 107–143
- Chartier L, Schiffrin E L, Thibult G, Garcia R. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogensis in vivo. Endocrinology 1984; 115: 2026–2028
- Volpe M, Odell G, Kleiner H D, Muller F, Camargo M J, Laragh J M, Maack T, Vaughn E D, Atlas S A. Effects of atrial natriuretic factor on blood pressure, renin and aldosterone in Goldbatt hypertension. Hypertension 1985; 7(Suppl. 1)143–148
- Kleiner H D, Maack T, Atlas S A, Sealey J E, Laragh J M. Atrial natriurertic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6(Suppl. 1)1143–1147
- Rankin A J. Mechanism for the release of atrial natriuretic peptide. Can J Physiol Pharmacol 1987; 65: 1673–1679